SELLAS Life Sciences Group, Inc.
SLS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001390478
No open-market purchases or sales by SELLAS Life Sciences Group, Inc. insiders were filed in the last 90 days; 193 institutions reported holding it in 13F filings for Q2 2026, worth $1.08B in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding SELLAS Life Sciences Group, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 30 | 30 | 0 |
| Shares | 7.74M | 4.08M | −3.66M (−47.3%) |
| Value | $7.82M | $4.86M | −$2.96M (−37.9%) |
New holders (9)
Institutions that held SELLAS Life Sciences Group, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Diametric Capital, LP | 153,019 | $182.1K | 0.10% |
| Millennium Management LLC | 150,448 | $179.0K | 0.00% |
| Prelude Capital Management, LLC | 55,726 | $66.3K | 0.01% |
| LPL Financial LLC | 51,894 | $61.8K | 0.00% |
| Renaissance Technologies LLC | 32,446 | $38.6K | 0.00% |
| Jane Street Group, LLC | 27,994 | $33.3K | 0.00% |
| Wedbush Securities Inc | 15,000 | $18.0K | 0.00% |
| Bank of America Corp | 577 | $687 | 0.00% |
| Jones Financial Companies LLLP | 374 | $445 | 0.00% |
Sold out (9)
Institutions that held SELLAS Life Sciences Group, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Anson Funds Management LP | 4,832,368 | $4.88M |
| Prosperity Financial Group, Inc. | 25,385 | $25.6K |
| Cantor Fitzgerald, L. P. | 24,750 | $25.0K |
| Citadel Advisors LLC | 19,718 | $19.9K |
| XTX Topco Ltd | 17,391 | $17.6K |
| Brooklyn FI, LLC | 11,178 | $11.3K |
| JPMorgan Chase & Co | 6,092 | $6.15K |
| Wells Fargo & Company | 301 | $304 |
| FMR LLC | 1 | $1 |